Encorafenib Plus Binimetinib for People With BRAF V600 Mutated Relapsed/Refractory HCL
Clinical trial NCT04324112 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04324112
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-28
- Primary completion
- 2026-05-20
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.